Impact Factor
4.93
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
12.52
12,774 total citations
h5-index
124
h5 depth signal
Cited share
92.1%
1,003 of 1,089
Total citations
12,774
Citation footprint
Metric signal
11.92
External metric anchor
Self-citation
0.8%
101 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
2,046
China
1,572
United Kingdom
812
Germany
559
Australia
383
Citing Fields of Research
Immunology
981
Genetics & Genomics
528
Virology
496
Oncology
490
Cancer & Development
376
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,416
Articles tracked across the journal lifetime
Indexed publication set
1,089
1,003 cited publications
Last 12 months
533
44.4 publications/month
Open access share
96.4%
514 OA publications in the last year
Leading citing country
United States
2,046 citing publications
Leading citing field
Immunology
981 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v2n1, Jan. 2015-
v1n1, Nov. 2014-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Neurodegenerative Disorders
Genetics & Genomics
Virology
Inflammatory Bowel Diseases & Infections
Oncology
Broad Categories
Genetics, Medical
Medicine
Virology
Genetics & Genomics
Neurodegenerative Disorders
Immunology
Inflammatory Bowel Diseases & Infections
HIV
MeSH Descriptors
Biomedical Research
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
DOI 10.1016/j.ebiom.2026.106506
Open DOI
CNPY3 variants associated with a recessive developmental and epileptic encephalopathy affect inflammasome and TLR function
05
DOI 10.1016/j.ebiom.2026.106502
Open DOI
Exploration of the genetic architecture of ANCA-associated vasculitis
06
07
DOI 10.1016/j.ebiom.2026.106519
Open DOI
Converging arboviral outbreaks demand disease-agnostic public health responses
08
DOI 10.1016/j.ebiom.2026.106508
Open DOI
Sustained type I interferon activity and N-antigenemia form a vicious cycle during severe COVID-19
09
DOI 10.1016/j.ebiom.2026.106514
Open DOI
The time has come: integrating vaccination and vector control for Aedes-borne disease prevention
10
DOI 10.1016/j.ebiom.2026.106505
Open DOI